Blog
Why most probiotics don’t survive the gut — and what engraftment actually takes
A look at the science behind strain colonization, and why prebiotic pairing changes the outcome.
We build synbiotics that actually engraft, and an AI platform that turns every user into a data point for better science.
Each part feeds the next — products generate data, data sharpens the AI, and the AI improves the next product.
Our AI discovery engine for synbiotics, precision biotics, and drug candidates, turning microbiome and clinical data into test-ready insight for us, and for partners.
Bacterial strains paired with the right prebiotics, so they establish themselves in the gut microbiome instead of just passing through, for maximum benefits.
Every synbiotic user adds longitudinal data back into the platform, sharpening the next product cycle.
Our first-in-class supplements support targeted wellness, which, based on user efficacy data, can be converted to a drug candidate for cure.
Wellness partners get differentiated products. Pharma partners get de-risked, real-world data. For consenting patients, physicians get individualized health insights.
Most probiotics are eliminated within hours. Ours are built to mimic the natural microbiome for higher efficacy from the bacteria in them.
Refined using signal from a large, growing user population, not a single small trial, so it keeps getting sharper.
Clinically validated, not just label claims. Customers test with a kit, track in the app, and see their own data.
GLP-1 weight-loss drugs cause real muscle loss along with fat loss. HyperTrophee helps that group hold onto, or rebuild, the muscle they’re losing.
Independent pharma M&A and licensing activity across the microbiome category since 2022, validation of where the science is headed, ahead of our own results.
A look at the science behind strain colonization, and why prebiotic pairing changes the outcome.